Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Bancroft

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Scientific Reports|November 4, 2025
A feasibility study of whole genome germline testing as an adjunct screening tool in a UK general private practiceAnn-Britt Jones, Gabriella Pichert, Lucy Side, et al.
Scientific Reports|June 25, 2013
Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk menEmma Killick, Richard Morgan, Francesca Launchbury, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 14, 2023
'A good decision is the one that feels right for me': Codesign with patients to inform theoretical underpinning of a decision aid websiteKelly Kohut, Kate Morton, Karen Hurley, et al.
European Urology|December 3, 2014
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate CancerElena Castro, Chee Goh, Daniel Leongamornlert, et al.
BMC Infectious Diseases|March 6, 2025
Implementation of an infection prevention and control response strategy to combat the Sudan Virus Disease outbreak in an urban setting, the Kampala Metropolitan area, Uganda, 2022S Judith Nanyondo, Shillah Nakato, Janelle Franklin, et al.
BJC Reports|November 8, 2024
Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genesSarah Benafif, Ann-Britt Jones, Susan Merson, et al.
BJU International|July 2, 2021
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screeningSarah Benafif, Holly Ni Raghallaigh, Eva McGrowder, et al.
European Urology|June 14, 2020
Prostate Cancer Risk by BRCA2 Genomic RegionsTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
European Urology|September 10, 2019
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort StudyTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Scientific Reports|November 4, 2025
A feasibility study of whole genome germline testing as an adjunct screening tool in a UK general private practiceAnn-Britt Jones, Gabriella Pichert, Lucy Side, et al.
Scientific Reports|June 25, 2013
Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk menEmma Killick, Richard Morgan, Francesca Launchbury, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 14, 2023
'A good decision is the one that feels right for me': Codesign with patients to inform theoretical underpinning of a decision aid websiteKelly Kohut, Kate Morton, Karen Hurley, et al.
European Urology|December 3, 2014
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate CancerElena Castro, Chee Goh, Daniel Leongamornlert, et al.
BMC Infectious Diseases|March 6, 2025
Implementation of an infection prevention and control response strategy to combat the Sudan Virus Disease outbreak in an urban setting, the Kampala Metropolitan area, Uganda, 2022S Judith Nanyondo, Shillah Nakato, Janelle Franklin, et al.
BJC Reports|November 8, 2024
Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genesSarah Benafif, Ann-Britt Jones, Susan Merson, et al.
BJU International|July 2, 2021
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screeningSarah Benafif, Holly Ni Raghallaigh, Eva McGrowder, et al.
European Urology|June 14, 2020
Prostate Cancer Risk by BRCA2 Genomic RegionsTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
European Urology|September 10, 2019
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort StudyTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.
Pageof 6